ARCHIVES

Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher

May 27, 1994

James Doroshow Named NCI Deputy Director, Clinical Research

June 10, 2011

Six NY Institutes Form Cancer Vaccine Collaboration

November 8, 2002

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

September 23, 1988

ASCO Proposes Principles For Future Debate on Medicaid

November 21, 2014

In Congress: Societies, Advocates, Testify For Increases In Research Funding

February 13, 1998